Skip to content
Screener

Madrigal Pharmaceuticals, Inc. MDGL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Viking Therapeutics logo
Viking TherapeuticsVKTX
$0-100%
Wave Life Sciences logo
Wave Life SciencesWVE
$39.5M+159%
Arrowhead Research logo
Arrowhead ResearchARWR
$42.79M-3.7%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
7.5%+0.1pp
Maze Therapeutics logo
Maze TherapeuticsMAZE
$19.29M-14.2%
Delcath Systems logo
Delcath SystemsDCTH
$2.46M+148%

Segments

By geography

See full
West Conshohocken, Pennsylvania$4M

Other financials

Income statement

See full
Revenue$364.3M+71.2%
Gross profit$43.5M
Operating income-$56.3M-19.3%
Net income-$57.9M-37.0%
EPS (diluted)-$1.99-4.7%

Balance sheet

See full
Cash & equivalents$292.9M+53.2%
Total debt$377.9M+179%
Total equity$523.7M-24.7%
Total assets$1.2B+22.6%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$4.3M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.79B+56.5%
Enterprise value$11.88B+58.8%
P/S9.2×-5.4×

Profitability

See full
Gross margin96.5%
Operating margin-25.1%-9.2pp
Net margin-25.3%-8.8pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-53.3%+47.0pp
Debt / equity0.7×+0.5×
Current ratio3.2×-1.9×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050845
Line itemJune 30,2026December 31,2025
Total current assets1,199,1801,245,770
Property and equipment, net11,5921,499
Intangible assets, net7,1877,381
Operating lease right-of-use assets5,5784,939
Other noncurrent assets21,108
Total assets$1,244,645$1,259,589
Liabilities and Stockholders’ Equity
Current liabilities:

Item 1. Financial Statements (Unaudited):

FAQ

What is Madrigal Pharmaceuticals, Inc.'s operating lease ROU assets?
Madrigal Pharmaceuticals, Inc. (MDGL) reported operating lease ROU assets of $5.58M in Q2 2026.
How has Madrigal Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 4.8% year-over-year, from $5.86M to $5.58M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 44.5% compound annual growth rate (CAGR), from $785K to $4.94M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Madrigal Pharmaceuticals, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude